A. Yamamoto

发表

Processing Parameters and Ion Excipients Affect the Physicochemical Characteristics of the Stereocomplex-Formed Polylactide-b-Polyethylene Glycol Nanoparticles and Their Pharmacokinetics

Kohei Ogawa, H. Katsumi, Yasushi Moroto, 2022, Pharmaceutics.

Intranasal rifampicin for Alzheimer's disease prevention

A. Yamamoto, T. Tomiyama, T. Umeda, 2018, Alzheimer's & dementia.

The development and characteristics of novel microneedle arrays fabricated from hyaluronic acid, and their application in the transdermal delivery of insulin.

Akira Yamamoto, H. Katsumi, A. Yamamoto, 2012, Journal of controlled release : official journal of the Controlled Release Society.

Cell-based interferon gene therapy using proliferation-controllable, interferon-releasing mesenchymal stem cells

M. Nishikawa, H. Katsumi, A. Yamamoto, 2019, Scientific Reports.

Oligoarginine-based prodrugs with self-cleavable spacers for caco-2 cell permeation.

S. Futaki, T. Fujita, Y. Kiso, 2008, Chemical & pharmaceutical bulletin.

Development of oligoarginine-drug conjugates linked to new peptidic self-cleavable spacers toward effective intestinal absorption.

S. Futaki, T. Fujita, Y. Kiso, 2007, Bioorganic & medicinal chemistry letters.

Creation and X-ray Structure Analysis of the Tumor Necrosis Factor Receptor-1-selective Mutant of a Tumor Necrosis Factor-α Antagonist*

Akira Yamamoto, Yasuo Yoshioka, Takao Hayakawa, 2008, Journal of Biological Chemistry.

The transnasal delivery of 5-fluorouracil to the rat brain is enhanced by acetazolamide (the inhibitor of the secretion of cerebrospinal fluid).

I. Hidalgo, S. Yamashita, H. Katsumi, 2009, International journal of pharmaceutics.

Chitosan capsules for colon-specific drug delivery: enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats.

Tsutomu Suzuki, T. Fujita, A. Yamamoto, 2002, Journal of controlled release : official journal of the Controlled Release Society.

Development of PEGylated serum albumin with multiple reduced thiols as a long-circulating scavenger of reactive oxygen species for the treatment of fulminant hepatic failure in mice.

M. Hashida, F. Yamashita, H. Okamoto, 2014, Free radical biology & medicine.

Rectal drug delivery systems Improvement of rectal peptide absorption by absorption enhancers, protease inhibitors and chemical modification

A. Yamamoto, S. Muranishi, 1997 .

Improvement of intestinal absorption of human calcitonin by chemical modification with fatty acids : synergistic effects of acylation and absorption enhancers

T. Fujita, A. Yamamoto, K. Morikawa, 1996 .

Nasal delivery of P-gp substrates to the brain through the nose-brain pathway.

I. Hidalgo, S. Yamashita, H. Katsumi, 2011, Drug metabolism and pharmacokinetics.

What kinds of substrates show P-glycoprotein-dependent intestinal absorption? Comparison of verapamil with vinblastine.

T. Fujita, S. Yamashita, M. Ozawa, 2006, Drug metabolism and pharmacokinetics.

Trypsin as a novel potential absorption enhancer for improving the transdermal delivery of macromolecules

H. Katsumi, A. Yamamoto, S. Tsutsumi, 2009 .

Transdermal delivery of insulin using trypsin as a biochemical enhancer.

H. Katsumi, A. Yamamoto, S. Tsutsumi, 2008, Biological & pharmaceutical bulletin.

Chitosan Capsules for Colon-Specific Drug Delivery: Improvement of Insulin Absorption from the Rat Colon

Tsutomu Suzuki, C. Tada, A. Yamamoto, 1997 .

Development of PEGylated Cysteine-Modified Lysine Dendrimers with Multiple Reduced Thiols To Prevent Hepatic Ischemia/Reperfusion Injury.

S. Kawakami, M. Hashida, F. Yamashita, 2016, Molecular pharmaceutics.

Utility of three-dimensional skin from human-induced pluripotent stem cells as a tool to evaluate transdermal drug permeation.

K. Kawabata, Tomoko Yamaguchi, H. Katsumi, 2019, Journal of pharmaceutical sciences.

Development of a Phosphoric Acid-Mediated Hyaluronic Acid Gel Sheet for Efficient Transdermal Delivery of Alendronate for Anti-Osteoporotic Therapy

H. Katsumi, Masaki Morishita, A. Yamamoto, 2019, Pharmaceutics.

Development of Novel Lipophilic Derivatives of DADLE (Leucine Enkephalin Analogue): Intestinal Permeability Characteristics of DADLE Derivatives in Rats

T. Fujita, Y. Kiso, A. Yamamoto, 2000, Pharmaceutical Research.

A Recirculatory Model with Enterohepatic Circulation by Measuring Portal and Systemic Blood Concentration Difference

A. Yamamoto, H. Yasui, T. Moriwaki, 2003, Journal of Pharmacokinetics and Pharmacodynamics.

Functional characteristics of H+-dependent nicotinate transport in primary cultures of astrocytes from rat cerebral cortex

T. Fujita, A. Yamamoto, Ayumi Shimada, 2006, Neuroscience Letters.

Regulation of proliferation and functioning of transplanted cells by using herpes simplex virus thymidine kinase gene in mice

M. Nishikawa, H. Katsumi, A. Yamamoto, 2018, Journal of controlled release : official journal of the Controlled Release Society.

Rectal and vaginal absorption of peptides and proteins

A. Yamamoto, S. Muranishi, H. Okada, 1993 .

Enhanced transdermal delivery of phenylalanyl-glycine by chemical modification with various fatty acids.

T. Fujita, A. Yamamoto, S. Muranishi, 2003, International journal of pharmaceutics.

Improvement of Transdermal Delivery of Tetragastrin by Lipophilic Modification with Fatty Acids

N. Araki, T. Fujita, A. Yamamoto, 1995, The Journal of pharmacy and pharmacology.

Insulin and proinsulin proteolysis in mucosal homogenates of the albino rabbit: implications in peptide delivery from nonoral routes.

V. H. Lee, A. Yamamoto, E. Hayakawa, 1990, Life sciences.

In vitro study on the transport of zinc across intestinal epithelial cells using Caco-2 monolayers and isolated rat intestinal membranes.

H. Katsumi, A. Yamamoto, Y. Yoshikawa, 2012, Biological & pharmaceutical bulletin.

The disposition and intestinal absorption of zinc in rats.

H. Katsumi, A. Yamamoto, Y. Yoshikawa, 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Nasal Drug Absorption from Powder Formulations: Effect of Fluid Volume Changes on the Mucosal Surface.

H. Katsumi, A. Yamamoto, A. Tanaka, 2017, Biological & pharmaceutical bulletin.

Penetration of 5-fluorouracil and prodrugs across the intestine of the albino rabbit: Evidence for shift in absorption site from the upper to the lower region of the gastrointestinal tract by prodrugs

V. H. Lee, A. Yamamoto, A. Buur, 1990 .

Pharmacokinetics of mitomycin C (MMC) after intraperitoneal administration of MMC-gelatin gel and its anti-tumor effects against sarcoma-180 bearing mice.

T. Fujita, A. Yamamoto, S. Muranishi, 1997, Journal of drug targeting.

Modulation of Intestinal Transport and Absorption of Topotecan, a BCRP Substrate, by Various Pharmaceutical Excipients and Their Inhibitory Mechanisms of BCRP Transporter.

H. Katsumi, Masaki Morishita, A. Yamamoto, 2019, Journal of pharmaceutical sciences.

Development of polyethylene glycol-conjugated alendronate, a novel nitrogen-containing bisphosphonate derivative: evaluation of absorption, safety, and effects after intrapulmonary administration in rats.

H. Katsumi, A. Yamamoto, T. Sakane, 2011, Journal of pharmaceutical sciences.

Absorption and safety of alendronate, a nitrogen-containing bisphosphonate, after intrapulmonary administration in rats.

T. Fujita, H. Katsumi, A. Yamamoto, 2010, International journal of pharmaceutics.

A Dense Layer of Polyethyleneglycol and Zwitterionic Bone Targeting Peptide on the Surface of Stereocomplex Polylactide-Polyethyleneglycol Nanoparticles Improves Shelf-Storage Stability and the Serum Compatibility.

Kohei Ogawa, H. Katsumi, Yasushi Moroto, 2022, Journal of pharmaceutical sciences.

Pharmacokinetic Analysis of Ramatroban Using a Recirculatory Model with Enterohepatic Circulation by Measuring Portal and Systemic Blood Concentration Difference in Sprague-Dawley and Eisai Hyperbilirubinemic Rats

A. Yamamoto, H. Yasui, T. Moriwaki, 2004, Pharmaceutical Research.

Assessment of contribution of BCRP to intestinal absorption of various drugs using portal‐systemic blood concentration difference model in mice

T. Fujita, A. Yamamoto, Y. Kono, 2020, Pharmacology research & perspectives.

Effects of Various Pharmaceutical Excipients on the Intestinal Transport and Absorption of Sulfasalazine, a Typical Substrate of Breast Cancer Resistance Protein Transporter.

H. Katsumi, Masaki Morishita, A. Yamamoto, 2018, Journal of pharmaceutical sciences.

P-glycoprotein Restricts the Penetration of Oseltamivir Across the Blood-Brain Barrier

H. Kusuhara, Y. Sugiyama, M. Kanai, 2008, Drug Metabolism and Disposition.

Improved tumor targetability of Tat-conjugated PAMAM dendrimers as a novel nanosized anti-tumor drug carrier

H. Katsumi, A. Yamamoto, T. Sakane, 2015, Drug development and industrial pharmacy.

Bone-targeting dendrimer for the delivery of methotrexate and treatment of bone metastasis

H. Katsumi, A. Yamamoto, T. Sakane, 2018, Journal of drug targeting.

Enhanced Oral Delivery of Bisphosphonate by Novel Absorption Enhancers: Improvement of Intestinal Absorption of Alendronate by N-Acyl Amino Acids and N-Acyl Taurates and Their Absorption-Enhancing Mechanisms.

Y. Nakaya, H. Katsumi, A. Yamamoto, 2016, Journal of pharmaceutical sciences.

Functional characterization of brain peptide transporter in rat cerebral cortex: identification of the high-affinity type H+/peptide transporter PEPT2

V. Ganapathy, T. Fujita, A. Yamamoto, 2004, Brain Research.

Development of PEGylated aspartic acid-modified liposome as a bone-targeting carrier for the delivery of paclitaxel and treatment of bone metastasis.

H. Katsumi, A. Yamamoto, Chihiro Naito, 2018, Biomaterials.

Title Molecular Design of Bisphosphonate-Modified Proteins forEfficient Bone Targeting In Vivo

M. Nishikawa, H. Katsumi, A. Yamamoto, 2018 .

Molecular Design of Bisphosphonate-Modified Proteins for Efficient Bone Targeting In Vivo

M. Nishikawa, H. Katsumi, A. Yamamoto, 2015, PloS one.

Effect of sodium glycocholate and polyoxyethylene-9-lauryl ether on the hydrolysis of varying concentrations of insulin in the nasal homogenates of the albino rabbit.

V. H. Lee, A. Yamamoto, E. Hayakawa, 1989, Life sciences.

Cardiovascular findings in familial hypercholesterolemic children.

Y. Arakaki, T. Kamiya, A. Yamamoto, 1991, Japanese circulation journal.

Improvement of intestinal absorption of insulin and water-soluble macromolecular compounds by chitosan oligomers in rats.

T. Fujita, H. Katsumi, A. Yamamoto, 2008, International journal of pharmaceutics.

Improvement of absorption enhancing effects of n-dodecyl-beta-D-maltopyranoside by its colon-specific delivery using chitosan capsules.

T. Fujita, G. Fetih, A. Yamamoto, 2005, International journal of pharmaceutics.

Modulating effect of polyethylene glycol on the intestinal transport and absorption of prednisolone, methylprednisolone and quinidine in rats by in‐vitro and in‐situ absorption studies

T. Fujita, H. Katsumi, A. Yamamoto, 2008 .

Metabolism of Azetirelin, a New Thyrotropin-releasing Hormone (TRH) Analogue, by Intestinal Microorganisms

T. Fujita, A. Yamamoto, S. Muranishi, 1997, Pharmaceutical Research.

Enhanced absorption of insulin and (Asu(1,7))eel-calcitonin using novel azopolymer-coated pellets for colon-specific drug delivery.

T. Fujita, A. Yamamoto, S. Muranishi, 2001, Journal of pharmaceutical sciences.

Colon-specific delivery and enhanced colonic absorption of [Asu1,7]-eel calcitonin using chitosan capsules containing various additives in rats

Mohammed Attia, T. Fujita, G. Fetih, 2006, Journal of drug targeting.

Modulation of intestinal P-glycoprotein function by polyethylene glycols and their derivatives by in vitro transport and in situ absorption studies.

Akira Yamamoto, Yulian Lin, T. Fujita, 2006, International journal of pharmaceutics.

Effects of Polyoxyethylene Alkyl Ethers on the Intestinal Transport and Absorption of Rhodamine 123: A P-glycoprotein Substrate by In Vitro and In Vivo Studies.

Wanting Zhao, H. Katsumi, A. Yamamoto, 2016, Journal of pharmaceutical sciences.

The effect of wellsolve, a novel solubilizing agent, on the intestinal barrier function and intestinal absorption of griseofulvin in rats.

H. Katsumi, A. Yamamoto, T. Sakane, 2009, Biological & pharmaceutical bulletin.

Improvement of Large Intestinal Absorption of Insulin by Chemical Modification with Palmitic Acid in Rats

A. Yamamoto, K. Takada, S. Muranishi, 1992, The Journal of pharmacy and pharmacology.

Improvement of Intestinal Absorption of Thyrotropin‐releasing Hormone by Chemical Modification with Lauric Acid

A. Yamamoto, K. Takada, S. Muranishi, 1992, The Journal of pharmacy and pharmacology.

Degradation of Insulin and Calcitonin and Their Protection by Various Protease Inhibitors in Rat Caecal Contents: Implications in Peptide Delivery to the Colon

T. Fujita, A. Yamamoto, S. Muranishi, 1997, The Journal of pharmacy and pharmacology.

Functional linkage of H+/peptide transporter PEPT2 and Na+/H+ exchanger in primary cultures of astrocytes from mouse cerebral cortex

T. Fujita, A. Yamamoto, N. Okada, 2005, Brain Research.

Conjunctival Penetration of Insulin and Peptide Drugs in the Albino Rabbit

V. H. Lee, Wei Wang, A. Yamamoto, 1992, Pharmaceutical Research.

The ocular route for systemic insulin delivery in the albino rabbit.

V. H. Lee, A. Yamamoto, V. Lee, 1989, The Journal of pharmacology and experimental therapeutics.

Functional Expression of Taurine Transporter and its Up-Regulation in Developing Neurons from Mouse Cerebral Cortex

T. Fujita, A. Yamamoto, Ayumi Shimada, 2006, Pharmaceutical Research.

Effects of polyamidoamine (PAMAM) dendrimers on the nasal absorption of poorly absorbable drugs in rats.

H. Katsumi, A. Yamamoto, T. Sakane, 2010, International journal of pharmaceutics.

Effect of absorption promoters on the nasal absorption of drugs with various molecular weights

M. Hashida, A. Yamamoto, H. Sezaki, 1993 .

Role of nuclear factor-κB in gastric ulcer healing in rats

T. Fujita, Satoru Takahashi, A. Yamamoto, 2001 .

Characterization of P-Glycoprotein Inhibitors for Evaluating the Effect of P-Glycoprotein on the Intestinal Absorption of Drugs

T. Fujita, A. Yamamoto, Y. Kono, 2021, Pharmaceutics.

In vitro evaluation of the ciliary beat frequency of the rat nasal epithelium using a high-speed digital imaging system.

H. Katsumi, A. Yamamoto, K. Higaki, 2013, Biological & pharmaceutical bulletin.

l-Cysteine and l-Serine Modified Dendrimer with Multiple Reduced Thiols as a Kidney-Targeting Reactive Oxygen Species Scavenger to Prevent Renal Ischemia/Reperfusion Injury

H. Katsumi, Masaki Morishita, A. Yamamoto, 2018, Pharmaceutics.

Immunological control of drug absorption from the gastrointestinal tract: the mechanism whereby intestinal anaphylaxis interferes with the intestinal absorption of bromthymol blue in the rat

M. Hashida, J. Nakamura, E. Utsumi, 1986, The Journal of pharmacy and pharmacology.

Approaches to improve intestinal and transmucosal absorption of peptide and protein drugs.

H. Katsumi, Masaki Morishita, A. Yamamoto, 2020, Pharmacology & therapeutics.

Absorption of water-soluble compounds with different molecular weights and.

T. Fujita, A. Yamamoto, S. Muranishi, 2001, Journal of controlled release : official journal of the Controlled Release Society.

Modulation of intestinal permeability by nitric oxide donors: implications in intestinal delivery of poorly absorbable drugs.

T. Fujita, A. Yamamoto, N. Okada, 2001, The Journal of pharmacology and experimental therapeutics.

Enhanced Permeability of Insulin across the Rat Intestinal Membrane by Various Absorption Enhancers: Their Intestinal Mucosal Toxicity and Absorption‐enhancing Mechanism of n‐Lauryl‐β‐D‐maltopyranoside

T. Fujita, A. Yamamoto, Y. Quan, 1999, The Journal of pharmacy and pharmacology.

Effects of various protease inhibitors on the stability and permeability of [D-Ala2,D-Leu5]enkephalin in the rat intestine: comparison with leucine enkephalin.

T. Fujita, A. Yamamoto, S. Muranishi, 1998, Journal of pharmaceutical sciences.

Effects of Different Absorption Enhancers on the Permeation of Ebiratide, an ACTH Analogue, across Intestinal Membranes

A. Yamamoto, S. Muranishi, S. Kondo, 1997, The Journal of pharmacy and pharmacology.

Improvement of the pulmonary absorption of (Asu1,7)-eel calcitonin by various absorption enhancers and their pulmonary toxicity in rats.

K. Takahashi, M. Fukui, A. Yamamoto, 1997, Journal of pharmaceutical sciences.

Pulmonary absorption enhancement of peptides by absorption enhancers and protease inhibitors

T. Fujita, A. Yamamoto, S. Muranishi, 1996 .

Effects of protease inhibitors on the absorption of phenol red and fluorescein isothiocyanate dextrans from the rat intestine.

T. Fujita, A. Yamamoto, Y. Quan, 1996, Journal of pharmaceutical sciences.

Absorption characteristics of chemically modified-insulin derivatives with various fatty acids in the small and large intestine.

T. Fujita, A. Yamamoto, S. Muranishi, 1995, Journal of pharmaceutical sciences.

Absorption Enhancement of Intrapulmonary Administered Insulin by Various Absorption Enhancers and Protease Inhibitors in Rats

A. Yamamoto, S. Muranishi, Shinji Umemori, 1994, The Journal of pharmacy and pharmacology.

Susceptibility of ebiratide to proteolysis in rat intestinal fluid and homogenates and its protection by various protease inhibitors.

T. Fujita, A. Yamamoto, S. Muranishi, 1994, Life sciences.

Pharmacokinetics and preventive effects of platinum nanoparticles as reactive oxygen species scavengers on hepatic ischemia/reperfusion injury in mice.

M. Oyama, H. Katsumi, A. Yamamoto, 2014, Metallomics : integrated biometal science.

[Study on the colon specific delivery of prednisolone using chitosan capsules].

A. Yamamoto, 2007, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

Gabapentin Blocks L-Type and P/Q-Type Ca2+ Channels Involved in Depolarization-Stimulated Nitric Oxide Synthase Activity in Primary Cultures of Neurons from Mouse Cerebral Cortex

Y. Itoh, T. Fujita, A. Yamamoto, 2003, Pharmaceutical Research.

A comparison of Ca2+ channel blocking mode between gabapentin and verapamil: implication for protection against hypoxic injury in rat cerebrocortical slices

Y. Itoh, T. Fujita, A. Yamamoto, 2003, British journal of pharmacology.

Development of PEGylated carboxylic acid-modified polyamidoamine dendrimers as bone-targeting carriers for the treatment of bone diseases.

H. Katsumi, A. Yamamoto, T. Sakane, 2017, Journal of controlled release : official journal of the Controlled Release Society.

sigma Receptor ligand-induced up-regulation of the H(+)/peptide transporter PEPT1 in the human intestinal cell line Caco-2.

V. Ganapathy, T. Fujita, F. Leibach, 1999, Biochemical and biophysical research communications.

L-Serine-Modified Poly-L-Lysine as a Biodegradable Kidney-Targeted Drug Carrier for the Efficient Radionuclide Therapy of Renal Cell Carcinoma

H. Kimura, H. Kawashima, H. Katsumi, 2022, Pharmaceutics.

S-nitrosylated l-serine-modified dendrimer as a kidney-targeting nitric oxide donor for prevention of renal ischaemia/reperfusion injury

H. Kimura, H. Katsumi, Masaki Morishita, 2019, Free radical research.

Hepatic and Intrahepatic Targeting of Hydrogen Sulfide Prodrug by Bioconjugation.

H. Katsumi, Masaki Morishita, A. Yamamoto, 2019, Biological & pharmaceutical bulletin.

Pharmacokinetics and Preventive Effects of Sulfo-Albumin as a Novel Macromolecular Hydrogen Sulfide Prodrug on Carbon Tetrachloride-Induced Hepatic Injury.

H. Katsumi, A. Yamamoto, T. Sakane, 2018, Journal of pharmaceutical sciences.

Improvement of the Pulmonary Absorption of (Asu1,7)-Eel Calcitonin by Various Protease Inhibitors in Rats

M. Hashida, Y. Takakura, A. Yamamoto, 1994, Pharmaceutical Research.

FR167653, a p38 mitogen-activated protein kinase inhibitor, prevents Helicobacter pylori-induced gastritis in Mongolian gerbils.

T. Fujita, A. Yamamoto, S. Takahashi, 2001, The Journal of pharmacology and experimental therapeutics.

H. Katsumi, A. Yamamoto, Y. Quan, 2017 .

Enhanced permeability of phenylalanyl-glycine (Phe-Gly) across the intestinal membranes by chemical modification with various fatty acids.

T. Fujita, A. Yamamoto, S. Muranishi, 2003, Drug metabolism and pharmacokinetics.

Interaction of kyotorphin and brain peptide transporter in synaptosomes prepared from rat cerebellum: implication of high affinity type H+/peptide transporter PEPT2 mediated transport system

V. Ganapathy, T. Fujita, A. Yamamoto, 1999, Neuroscience Letters.

Enhancement of the small intestinal uptake of phenylalanylglycine via a H+/oligopeptide transport system by chemical modification with fatty acids.

T. Fujita, A. Yamamoto, S. Muranishi, 1997, Life sciences.

Improvement of intestinal absorption of curcumin by cyclodextrins and the mechanisms underlying absorption enhancement.

H. Katsumi, Masaki Morishita, A. Yamamoto, 2018, International journal of pharmaceutics.

Permeation of sumatriptan succinate across human skin using multiple types of self-dissolving microneedle arrays fabricated from sodium hyaluronate

H. Katsumi, A. Yamamoto, Y. Quan, 2016, Journal of drug targeting.

Functional expression and adaptive regulation of Na+-dependent neutral amino acid transporter SNAT2/ATA2 in normal human astrocytes under amino acid starved condition

T. Fujita, A. Yamamoto, Kazunari Tanaka, 2005, Neuroscience Letters.

Polyamidoamine dendrimers as novel potential absorption enhancers for improving the small intestinal absorption of poorly absorbable drugs in rats.

H. Katsumi, A. Yamamoto, T. Sakane, 2011, Journal of controlled release : official journal of the Controlled Release Society.

The effect of polysorbate 80 on brain uptake and analgesic effect of D-kyotorphin

M. Hashida, H. Ueda, H. Takagi, 1989 .

Absorption Promotion Properties of Chitosan and Derivatives

A. Yamamoto, 2012 .

Excellent absorption enhancing characteristics of NO donors for improving the intestinal absorption of poorly absorbable compound compared with conventional absorption enhancers.

T. Fujita, G. Fetih, H. Katsumi, 2006, Drug metabolism and pharmacokinetics.

Nitric oxide donors can enhance the intestinal transport and absorption of insulin and [Asu(1,7)]-eel calcitonin in rats.

T. Fujita, G. Fetih, A. Yamamoto, 2005, Journal of controlled release : official journal of the Controlled Release Society.

Chitosan capsules for colon-specific drug delivery: improvement of insulin absorption from the rat colon.

T. Maruyama, C. Tada, A. Yamamoto, 1996, Journal of pharmaceutical sciences.

Development of a novel self-dissolving microneedle array of alendronate, a nitrogen-containing bisphosphonate: evaluation of transdermal absorption, safety, and pharmacological effects after application in rats.

H. Katsumi, A. Yamamoto, Y. Quan, 2012, Journal of pharmaceutical sciences.

Orthogonal Characterization and Pharmacokinetic Studies of Polylactide-Polyethyleneglycol Polymeric Nanoparticles with Different Physicochemical Properties.

Kohei Ogawa, H. Katsumi, Yasushi Moroto, 2021, International journal of pharmaceutics.

[Development of delivery system of bisphosphonates for the treatment of osteoporosis].

H. Katsumi, A. Yamamoto, T. Sakane, 2010, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

Enhanced Intestinal Absorption of Insulin by Capryol 90, a Novel Absorption Enhancer in Rats: Implications in Oral Insulin Delivery

H. Katsumi, Masaki Morishita, A. Yamamoto, 2020, Pharmaceutics.

Absorption-Enhancing Mechanisms of Capryol 90, a Novel Absorption Enhancer, for Improving the Intestinal Absorption of Poorly Absorbed Drugs: Contributions to Trans- or Para-Cellular Pathways

H. Katsumi, Masaki Morishita, A. Yamamoto, 2020, Pharmaceutical Research.

Propylene glycol caprylate as a novel potential absorption enhancer for improving the intestinal absorption of insulin: efficacy, safety and absorption-enhancing mechanisms.

H. Katsumi, Masaki Morishita, A. Yamamoto, 2019, Journal of pharmaceutical sciences.

Functional characterization of extracellular vesicles from baker's yeast Saccharomyces cerevisiae as a novel vaccine material for immune cell maturation.

H. Katsumi, Masaki Morishita, A. Yamamoto, 2022, Journal of pharmaceutical sciences.

Neurogastroenterology and Motility Role of transient receptor potential melastatin 2 in surgical inﬂammation and dysmotility in a mouse model of postoperative ileus

A. Yamamoto, H. Ozaki, M. Hori, 2018 .

Cellular interaction and in vitro antitumor activity of mitomycin C-dextran conjugate.

M. Hashida, Y. Takakura, A. Yamamoto, 1986, Cancer research.

Absorption and metabolic characteristics of p-aminobenzoic acid and its isomer, m-aminobenzoic acid, from the rat small intestine.

M. Shibukawa, M. Hashida, A. Yamamoto, 1991, Journal of pharmaceutical sciences.

Antigen-induced decrease of salicylic acid absorption from the small intestine in actively immunized rats.

J. Nakamura, A. Yamamoto, H. Sezaki, 1982, Journal of pharmacobio-dynamics.

Colon-specific delivery of R68070, a new thromboxane synthase inhibitor, using chitosan capsules: therapeutic effects against 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis in rats.

T. Fujita, A. Yamamoto, S. Muranishi, 1999, Life sciences.

Nasal drug absorption from powder formulations: The effect of three types of hydroxypropyl cellulose (HPC)

H. Katsumi, A. Yamamoto, A. Tanaka, 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

The Enhancement of Nasal Drug Absorption From Powder Formulations by the Addition of Sodium Carboxymethyl Cellulose

H. Katsumi, A. Yamamoto, A. Tanaka, 2016, IEEE Transactions on NanoBioscience.

Intestinal absorption of azetirelin, a new thyrotropin-releasing hormone (TRH) analogue. I. Possible factors for the low oral bioavailability in rats.

T. Fujita, A. Yamamoto, S. Muranishi, 1994, Biological & pharmaceutical bulletin.

Validation of a Pharmacokinetic Model of Colon‐specific Drug Delivery and the Therapeutic Effects of Chitosan Capsules Containing 5‐Aminosalicylic Acid on 2,4,6‐Trinitrobenzenesulphonic Acid‐induced Colitis in Rats

T. Fujita, A. Yamamoto, S. Muranishi, 1999, The Journal of pharmacy and pharmacology.

The Effect of Immunization with Protein‐sulphanilic Acid Conjugate on Sulphanilic Acid Disposition in the Rat

M. Hashida, A. Yamamoto, H. Sezaki, 1991, The Journal of pharmacy and pharmacology.

Effectiveness and toxicity screening of various absorption enhancers using Caco-2 cell monolayers.

T. Fujita, A. Yamamoto, S Muranishi, 1998, Biological & pharmaceutical bulletin.

Effects of various absorption enhancers on the intestinal absorption of water soluble drugs by in vitro Ussing chamber method: correlation with an in situ absorption experiment.

A. Yamamoto, Y. Quan, S. Muranishi, 1997, Biological & pharmaceutical bulletin.

Effectiveness and Toxicity Screening of Various Absorption Enhancers in the Rat Small Intestine: Effects of Absorption Enhancers on the Intestinal Absorption of Phenol Red and the Release of Protein and Phospholipids from the Intestinal Membrane

T. Fujita, A. Yamamoto, S. Muranishi, 1996, The Journal of pharmacy and pharmacology.

Mucosal penetration enhancers for facilitation of peptide and protein drug absorption.

U. Kompella, V. Lee, A. Yamamoto, 1991, Critical reviews in therapeutic drug carrier systems.

Penetration and enzymatic barriers to peptide and protein absorption

Akira Yamamoto, V. H. Lee, A. Yamamoto, 1989 .

Modulating effect of polyethylene glycol on the intestinal transport and absorption of prednisolone, methylprednisolone and quinidine in rats by in-vitro and in-situ absorption studies.

Akira Yamamoto, Yulian Lin, T. Fujita, 2008, The Journal of pharmacy and pharmacology.

Improvement of transdermal delivery of sumatriptan succinate using a novel self-dissolving microneedle array fabricated from sodium hyaluronate in rats.

H. Katsumi, A. Yamamoto, Y. Quan, 2015, Biological & pharmaceutical bulletin.

Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin.

Akira Yamamoto, H. Katsumi, A. Yamamoto, 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Intradermal concentration of hydroquinone after application of hydroquinone ointments is higher than its cytotoxic concentration.

T. Fujita, T. Sakaeda, K. Nishiguchi, 2003, Biological & pharmaceutical bulletin.

Effects of various storage conditions and alterations of antioxidant contents on chromatic aberration of hydroquinone ointment.

M. Ichihashi, J. Nordlund, T. Fujita, 2003, Biological & pharmaceutical bulletin.

Pharmaceutical and clinical assessment of hydroquinone ointment prepared by extemporaneous nonsterile compounding.

M. Hirai, M. Ichihashi, J. Nordlund, 2002, Biological & pharmaceutical bulletin.

Assessment of pharmaceutical excipient-induced gastrointestinal mucosal damage in rats in vivo by measuring the permeation of phenolsulfonphthalein.

S. Ueda, J. Nakamura, A. Yamamoto, 1985, Chemical & pharmaceutical bulletin.

Chitosan oligomers as potential and safe absorption enhancers for improving the pulmonary absorption of interferon-alpha in rats.

T. Fujita, M. Odomi, A. Yamamoto, 2005, Journal of pharmaceutical sciences.

Functional and molecular identification of sodium‐coupled dicarboxylate transporters in rat primary cultured cerebrocortical astrocytes and neurons

V. Ganapathy, T. Fujita, A. Yamamoto, 2006, Journal of neurochemistry.

The Effect of Absorption-Enhancement and the Mechanism of the PAMAM Dendrimer on Poorly Absorbable Drugs

A. Yamamoto, Yifei Guo, Chunyan Zhu, 2018, Molecules.

Improvement of intestinal absorption of water-soluble macromolecules by various polyamines: intestinal mucosal toxicity and absorption-enhancing mechanism of spermine.

T. Fujita, H. Katsumi, A. Yamamoto, 2008, International journal of pharmaceutics.

Improvement of pulmonary absorption of insulin and other water-soluble compounds by polyamines in rats.

T. Fujita, H. Katsumi, A. Yamamoto, 2007, Journal of controlled release : official journal of the Controlled Release Society.

Improvement of the Solubility and Intestinal Absorption of Curcumin by N-Acyl Taurates and Elucidation of the Absorption-Enhancing Mechanisms.

H. Katsumi, Masaki Morishita, A. Yamamoto, 2017, Biological & pharmaceutical bulletin.

Self-Dissolving Microneedle Arrays for Transdermal Absorption Enhancement of Human Parathyroid Hormone (1-34)

Akira Yamamoto, H. Katsumi, A. Yamamoto, 2018, Pharmaceutics.

Efficient Transdermal Delivery of Alendronate, a Nitrogen-Containing Bisphosphonate, Using Tip-Loaded Self-Dissolving Microneedle Arrays for the Treatment of Osteoporosis

Akira Yamamoto, H. Katsumi, A. Yamamoto, 2017, Pharmaceutics.

Improvement of Transdermal Delivery of Exendin-4 Using Novel Tip-Loaded Microneedle Arrays Fabricated from Hyaluronic Acid.

Akira Yamamoto, H. Katsumi, A. Yamamoto, 2016, Molecular pharmaceutics.

Development of a drug-coated microneedle array and its application for transdermal delivery of interferon alpha

Akira Yamamoto, H. Katsumi, A. Yamamoto, 2016, Biofabrication.

Effects of Various Protease Inhibitors on the Intestinal Absorption and Degradation of Insulin in Rats

Akira Yamamoto, T. Fujita, A. Yamamoto, 1994, Pharmaceutical Research.

Absorption enhancing effects of chitosan oligomers on the intestinal absorption of low molecular weight heparin in rats.

Hailong Zhang, Xiaoyan Huang, J. Xing, 2014, International journal of pharmaceutics.

Effect of absorption enhancers on pulmonary absorption of fluorescein isothiocyanate dextrans with various molecular weights

A. Yamamoto, K. Takada, S. Muranishi, 1991 .

Enhanced gastrointestinal absorption of drugs in rats pretreated with the synthetic immunomodulator, levamisole

M. Hashida, A. Yamamoto, T. Sakane, 1987, The Journal of pharmacy and pharmacology.

Immunological control of drug absorption from the gastrointestinal tract: effect of local anaphylaxis on the intestinal absorption of low molecular weight drugs in the rat.

M. Hashida, J. Nakamura, E. Utsumi, 1985, Journal of pharmacobio-dynamics.

Drug absorption from the gastrointestinal tract and immunity: the mechanism of the decreased absorption of salicylic acid during systemic anaphylaxis. I.

M. Hashida, J. Nakamura, A. Yamamoto, 1984, Journal of pharmacobio-dynamics.

An assessment of gastric ulcers in vivo: enhancement of urinary recovery after oral administration of phenolsulfonphthalein in rats.

S. Ueda, J. Nakamura, A. Yamamoto, 1984, Journal of pharmacobio-dynamics.

Effect of systemic anaphylaxis on the absorption of salicylic acid from the rat small intestine.

J. Nakamura, A. Yamamoto, H. Sezaki, 1984, Journal of pharmaceutical sciences.

An assessment of indomethacin‐induced gastrointestinal mucosal damage in‐vivo: enhancement of urinary recovery after oral administration of phenolsulfonphthalein in rats

J. Nakamura, A. Yamamoto, Toshikiro Kimura, 1983, The Journal of pharmacy and pharmacology.

Enhanced oral delivery of alendronate by sucrose fatty acids esters in rats and their absorption-enhancing mechanisms.

H. Katsumi, A. Yamamoto, T. Sakane, 2016, International journal of pharmaceutics.

Effects of 2 Polyoxyethylene Alkyl Ethers on the Function of Intestinal P-glycoprotein and Their Inhibitory Mechanisms.

Wanting Zhao, H. Katsumi, A. Yamamoto, 2016, Journal of pharmaceutical sciences.

Modulation of intestinal P-glycoprotein function by cremophor EL and other surfactants by an in vitro diffusion chamber method using the isolated rat intestinal membranes.

Akira Yamamoto, T. Fujita, A. Yamamoto, 2004, Journal of pharmaceutical sciences.

Colon-specific delivery of peptide drugs and anti-inflammatory drugs using chitosan capsules

T. Fujita, A. Yamamoto, H. Tozaki, 2000 .

Enhanced pulmonary bioavailability of curcumin by some common excipients and relative therapeutic effects on sepsis-induced acute lung injury in rats

Hailong Zhang, Xiaoyan Huang, Yang Gao, 2017 .

Long-term drug modification to the surface of mesenchymal stem cells by the avidin-biotin complex method

M. Nishikawa, H. Katsumi, A. Yamamoto, 2017, Scientific Reports.

[Improvement of transmucosal absorption of biologically active peptide drugs].

A. Yamamoto, 2001, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

Effect of immunomodulator on drug absorption from the gastrointestinal tract: the mechanism whereby levamisole enhanced the intestinal absorption of sulfanilamide in the rat

M. Hashida, E. Utsumi, A. Yamamoto, 1989 .

Use of Protease Inhibitors to Improve Calcitonin Absorption from the Small and Large Intestine in Rats

T. Fujita, A. Yamamoto, S. Muranishi, 1998, The Journal of pharmacy and pharmacology.

Transnasal delivery of methotrexate to brain tumors in rats: a new strategy for brain tumor chemotherapy.

S. Yamashita, H. Katsumi, A. Yamamoto, 2010, Molecular pharmaceutics.

Enhancement of intestinal transport of thyrotropin-releasing hormone via a carrier-mediated transport system by chemical modification with lauric acid.

T. Fujita, A. Yamamoto, Y. Yamamoto, 1996, Biochimica et biophysica acta.

Transport characteristics of N‐acetyl‐l‐aspartate in rat astrocytes: involvement of sodium‐coupled high‐affinity carboxylate transporter NaC3/NaDC3‐mediated transport system

V. Ganapathy, T. Fujita, A. Yamamoto, 2005, Journal of neurochemistry.

Improvement of intestinal absorption of azetirelin, a new TRH analogue, by absorption enhancers.

T. Fujita, A. Yamamoto, S. Muranishi, 1994 .

Delivery of Oxytocin to the Brain for the Treatment of Autism Spectrum Disorder by Nasal Application.

A. Kiriyama, H. Katsumi, A. Yamamoto, 2018, Molecular pharmaceutics.

Transnasal delivery of the peptide agonist specific to Neuromedin-U receptor2 to the brain for the treatment of obesity.

K. Mori, K. Kangawa, A. Kiriyama, 2019, Molecular pharmaceutics.

[Improvement of intestinal absorption of poorly absorbable drugs by various sugar esters].

H. Katsumi, A. Yamamoto, T. Sakane, 2014, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

Characterizing Different Probiotic-Derived Extracellular Vesicles as a Novel Adjuvant for Immunotherapy.

H. Katsumi, Masaki Morishita, A. Yamamoto, 2021, Molecular pharmaceutics.

Nonsteroidal anti-inflammatory drug-induced acute gastric injury in Helicobacter pylori gastritis in Mongolian gerbils.

T. Fujita, A. Yamamoto, S. Takahashi, 2000, European journal of pharmacology.

Trypsin as a novel potential absorption enhancer for improving the transdermal delivery of macromolecules.

H. Katsumi, A. Yamamoto, S. Tsutsumi, 2009, The Journal of pharmacy and pharmacology.

Anticancer drug-loaded mesenchymal stem cells for targeted cancer therapy.

M. Nishikawa, H. Katsumi, A. Yamamoto, 2020, Journal of controlled release : official journal of the Controlled Release Society.

ς Receptor Ligand-Induced Up-Regulation of the H+/Peptide Transporter PEPT1 in the Human Intestinal Cell Line Caco-2

V. Ganapathy, T. Fujita, A. Yamamoto, 1999 .

Evaluation of insulin permeability and effects of absorption enhancers on its permeability by an in vitro pulmonary epithelial system using Xenopus pulmonary membrane.

T. Fujita, H. Tanaka, A. Yamamoto, 2001, Biological and Pharmaceutical Bulletin.

Stability of Acyl Derivatives of Insulin in the Small Intestine: Relative Importance of Insulin Association Characteristics in Aqueous Solution

T. Fujita, A. Yamamoto, S. Muranishi, 1994, Pharmaceutical Research.

Absorption-enhancing effects of gemini surfactant on the intestinal absorption of poorly absorbed hydrophilic drugs including peptide and protein drugs in rats.

H. Katsumi, A. Yamamoto, T. Sakane, 2016, International journal of pharmaceutics.

Development of New Lipophilic Derivatives of Tetragastrin: Physicochemical Characteristics and Intestinal Absorption of Acyl-tetragastrin Derivatives in Rats

T. Fujita, A. Yamamoto, S. Muranishi, 1993, Pharmaceutical Research.

Effects of various absorption promoters on pulmonary absorption of drugs with different molecular weights.

M. Hashida, A. Yamamoto, H Sezaki, 1993, Biological & pharmaceutical bulletin.

Improvement of transmucosal absorption of peptide and protein drugs.

A. Yamamoto, 2000 .

Improvement of Transmucosal Absorption of Peptide and Protein Drugs

A. Yamamoto, 1997 .

Potential for lymphatic targeting of peptides

T. Fujita, A. Yamamoto, S. Muranishi, 1997 .

Role of nuclear factor-kappaB in gastric ulcer healing in rats.

T. Fujita, A. Yamamoto, S. Takahashi, 2001, American journal of physiology. Gastrointestinal and liver physiology.

A mechanistic study on enhancement of rectal permeability to insulin in the albino rabbit.

V. H. Lee, A. Yamamoto, A. Nishiura, 1992, The Journal of pharmacology and experimental therapeutics.

Functional characterization of Na+-independent choline transport in primary cultures of neurons from mouse cerebral cortex

T. Fujita, A. Yamamoto, N. Okada, 2006, Neuroscience Letters.

Electrophysiological studies on the mechanism for enhanced intestinal transport of water-soluble compounds by antibiotic peptide bacitracin.

T. Fujita, A. Yamamoto, Y. Quan, 1999, Biological & pharmaceutical bulletin.

Mechanistic Studies on the Absorption-Enhancing Effects of Gemini Surfactant on the Intestinal Absorption of Poorly Absorbed Hydrophilic Drugs in Rats

H. Katsumi, Masaki Morishita, A. Yamamoto, 2019, Pharmaceutics.

Effects of Labrasol and other pharmaceutical excipients on the intestinal transport and absorption of rhodamine123, a P-glycoprotein substrate, in rats.

Akira Yamamoto, Xuehua Jiang, Yulian Lin, 2007, Biological & pharmaceutical bulletin.

In vitro evaluation of nasal mucociliary clearance using excised rat nasal septum.

H. Katsumi, A. Yamamoto, K. Higaki, 2012, Biological & pharmaceutical bulletin.

Novel Strategy for the Systemic Delivery of Furosemide Based on a New Drug Transport Mechanism.

A. Kiriyama, H. Katsumi, A. Yamamoto, 2018, Biological & pharmaceutical bulletin.

Polyamidoamine dendrimers can improve the pulmonary absorption of insulin and calcitonin in rats.

H. Katsumi, A. Yamamoto, T. Sakane, 2011, Journal of pharmaceutical sciences.

Development of a novel transdermal patch of alendronate, a nitrogen‐containing bisphosphonate, for the treatment of osteoporosis

Akira Yamamoto, H. Katsumi, A. Yamamoto, 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Nasal Absorption of Macromolecules from Powder Formulations and Effects of Sodium Carboxymethyl Cellulose on Their Absorption

H. Katsumi, A. Yamamoto, A. Tanaka, 2016, PloS one.

Role of cyclooxygenase-2 in Helicobacter pylori- induced gastritis in Mongolian gerbils.

T. Fujita, A. Yamamoto, S. Takahashi, 2000, American journal of physiology. Gastrointestinal and liver physiology.

Comparison of the Permeability of Macromolecular Drugs Across Cultured Intestinal and Alveolar Epithelial Cell Monolayers

T. Fujita, A. Yamamoto, S. Muranishi, 2011 .

Functional expression of metabotropic GABAB receptors in primary cultures of astrocytes from rat cerebral cortex.

Qiang Wu, T. Fujita, A. Yamamoto, 2006, Biochemical and biophysical research communications.

Activation of Host Immune Cells by Probiotic-Derived Extracellular Vesicles via TLR2-Mediated Signaling Pathways.

H. Katsumi, Masaki Morishita, A. Yamamoto, 2022, Biological & pharmaceutical bulletin.

A chemically stable peptide agonist to neuromedin U receptor type 2.

K. Mori, N. Minamino, K. Kangawa, 2020, Bioorganic & Medicinal Chemistry.

Discovery of a Human Neuromedin U Receptor 1-Selective Hexapeptide Agonist with Enhanced Serum Stability.

K. Mori, N. Minamino, K. Kangawa, 2017, Journal of medicinal chemistry.

Pharmacokinetic and therapeutic efficacy of intrapulmonary administration of zoledronate for the prevention of bone destruction in rheumatoid arthritis

H. Katsumi, A. Yamamoto, T. Sakane, 2016, Journal of drug targeting.

Susceptibility of insulin to proteolysis in rat lung homogenate and its protection from proteolysis by various protease inhibitors.

T. Fujita, A. Yamamoto, T. Tsuji, 1995, Biological & pharmaceutical bulletin.

Transport of Drugs Across the Xenopus Pulmonary Membrane and Their Absorption Enhancement by Various Absorption Enhancers

T. Fujita, A. Yamamoto, S. Muranishi, 1996, Pharmaceutical Research.

Synthesis of Tat tagged and folate modified N-succinyl-chitosan self-assembly nanoparticles as a novel gene vector.

H. Katsumi, A. Yamamoto, T. Sakane, 2015, International journal of biological macromolecules.

Functional characterization of Zn2+-sensitive GABA transporter expressed in primary cultures of astrocytes from rat cerebral cortex

Qiang Wu, T. Fujita, A. Yamamoto, 2006, Brain Research.

Improvement of intestinal absorption of biologically active peptides by chemical modification with fatty acids.

A. Yamamoto, S. Muranishi, 1997 .

Intestinal Absorption of Insulin in the Absence of Intestinal-fluid Enzymes

A. Yamamoto, S. Muranishi, H. Tozaki, 1996 .

Intestinal absorption of azetirelin, a new thyrotropin-releasing hormone (TRH) analogue. II. In situ and in vitro absorption characteristics of azetirelin from the rat intestine.

T. Fujita, A. Yamamoto, K. Tanaka, 1995, Biological & pharmaceutical bulletin.

Enhanced permeability of tetragastrin across the rat intestinal membrane and its reduced degradation by acylation with various fatty acids.

K. Uemura, T. Fujita, A. Yamamoto, 1994, The Journal of pharmacology and experimental therapeutics.

Development of a novel transdermal patch containing sumatriptan succinate for the treatment of migraine: in vitro and in vivo characterization

H. Katsumi, A. Yamamoto, Y. Quan, 2014 .

Importance of the Direct Contact of Amorphous Solid Particles with the Surface of Monolayers for the Transepithelial Permeation of Curcumin.

H. Katsumi, A. Yamamoto, A. Tanaka, 2016, Molecular pharmaceutics.

Calcein is excreted from the intestinal mucosal cell membrane by the active transport system.

T. Fujita, A. Yamamoto, S. Muranishi, 1996, Life sciences.

Functional expression of constitutive nitric oxide synthases regulated by voltage‐gated Na+ and Ca2+ channels in cultured human astrocytes

Y. Itoh, T. Fujita, A. Yamamoto, 2004, Glia.

Intestinal Transport of Sulfanilic Acid in Rats Immunized with Protein–Sulfanilic Acid Conjugate

M. Hashida, A. Yamamoto, H. Sezaki, 1990, Pharmaceutical Research.

The effect of immunization with protein-hapten conjugate on the intestinal uptake of p-aminobenzoic acid as a hapten.

M. Hashida, A. Yamamoto, T. Sakane, 1989, Life sciences.

Enhanced absorption of salicylic acid and sulfanilamide by the synthetic immunomodulator levamisole in rats

M. Hashida, E. Utsumi, A. Yamamoto, 1987 .

The effects of common solubilizing agents on the intestinal membrane barrier functions and membrane toxicity in rats.

H. Katsumi, A. Yamamoto, T. Sakane, 2009, International journal of pharmaceutics.

Effectiveness and toxicity screening of various absorption enhancers in the large intestine: intestinal absorption of phenol red and protein and phospholipid release from the intestinal membrane.

T. Fujita, A. Yamamoto, S. Muranishi, 1996, Biological & pharmaceutical bulletin.

[Effect of Probiotic-derived Extracellular Vesicles on Innate Immunity and Their Usability].

H. Katsumi, Masaki Morishita, A. Yamamoto, 2023, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

Bone-Targeted Drug Delivery Systems and Strategies for Treatment of Bone Metastasis.

H. Katsumi, Masaki Morishita, A. Yamamoto, 2020, Chemical and pharmaceutical bulletin.

Comparison of Various Cell Lines and Three-Dimensional Mucociliary Tissue Model Systems to Estimate Drug Permeability Using an In Vitro Transport Study to Predict Nasal Drug Absorption in Rats

H. Katsumi, A. Yamamoto, A. Tanaka, 2020, Pharmaceutics.

Quantitative Estimation of the Effect of Nasal Mucociliary Function on in Vivo Absorption of Norfloxacin after Intranasal Administration to Rats.

A. Kiriyama, H. Katsumi, A. Yamamoto, 2018, Molecular pharmaceutics.

The relationship between in vivo nasal drug clearance and in vitro nasal mucociliary clearance: Application to the prediction of nasal drug absorption

A. Kiriyama, H. Katsumi, A. Yamamoto, 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Does bacitracin have an absorption-enhancing effect in the intestine?

T. Fujita, A. Yamamoto, S. Muranishi, 1995, Biological & pharmaceutical bulletin.

Lymphatic transfer of macromolecules after intrapulmonary administration in the presence or absence of various absorption enhancers in rats.

T. Fujita, A. Yamamoto, S. Muranishi, 1996, Die Pharmazie.

Dendrimer-based micelles with highly potent targeting to sites of active bone turnover for the treatment of bone metastasis.

H. Kimura, H. Katsumi, A. Yamamoto, 2020, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Quick and Simultaneous Analysis of Dissolved Active Pharmaceutical Ingredients and Formulation Excipients from the Dissolution Test Utilizing UHPLC and Charged Aerosol Detector

H. Katsumi, A. Yamamoto, T. Sakane, 2021, AAPS PharmSciTech.

Improved dissolution and absorption of ketoconazole in the presence of organic acids as pH-modifiers.

Koichi Wada, H. Katsumi, A. Yamamoto, 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Carrageenans can regulate the pulmonary absorption of antiasthmatic drugs and their retention in the rat lung tissues without any membrane damage.

T. Fujita, M. Odomi, S. Kohno, 2005, International journal of pharmaceutics.

Evaluation of Drug Absorption After Intrapulmonary Administration Using Xenopus Pulmonary Membranes: Correlation with In Vivo Pulmonary Absorption Studies in Rats

A. Yamamoto, S. Muranishi, K. Shinsako, 1997, Pharmaceutical Research.

Control of pulmonary absorption of water-soluble compounds by various viscous vehicles.

T. Fujita, A. Yamamoto, S. Muranishi, 2004, International journal of pharmaceutics.

The impact of breast cancer resistant protein (BCRP/ABCG2) on drug transport across Caco-2 cell monolayers.

T. Fujita, A. Yamamoto, Y. Kono, 2020, Drug metabolism and disposition: the biological fate of chemicals.

Assessment of Drug Disposition in the Perfused Rat Brain by Statistical Moment Analysis

Mitsuru Hashida, Akira Yamamoto, Hitoshi Sezaki, 1991, Pharmaceutical Research.

l-Serine–modified polyamidoamine dendrimer as a highly potent renal targeting drug carrier

H. Kimura, Yusuke Yagi, K. Koshino, 2018, Proceedings of the National Academy of Sciences.

Pharmaceutical and clinical assessment of hydroquinone ointment prepared by extemporaneous nonsterile compounding.

M. Hirai, M. Ichihashi, J. Nordlund, 2002, Biological & pharmaceutical bulletin.

Absorption-improving effects of chitosan oligomers based on their mucoadhesive properties: a comparative study on the oral and pulmonary delivery of calcitonin

Hailong Zhang, Xiaoyan Huang, Ya Sun, 2016, Drug delivery.

Biodegradation and Medical Application of Chitosan Hard Capsule

Tsutomu Suzuki, A. Yamamoto, Takayuki Matsumoto, 1998 .

Colon‐specific Delivery of Budesonide with Azopolymer‐coated Pellets: Therapeutic Effects of Budesonide with a Novel Dosage Form against 2,4,6‐Trinitrobenzenesulphonic Acid‐induced Colitis in Rats

T. Fujita, A. Yamamoto, S. Muranishi, 1999, The Journal of pharmacy and pharmacology.

Permeability of macromolecules in cultured endothelial and tumor cell layers on microporous membranes

Y. Takakura, A. Yamamoto, H. Sezaki, 1992 .

Development of PEGylated serum albumin with multiple reduced thiols as a long-circulating scavenger of reactive oxygen species for the treatment of fulminant hepatic failure in mice.

M. Hashida, F. Yamashita, H. Okamoto, 2014, Free radical biology & medicine.

Importance of the Direct Contact of Amorphous Solid Particles with the Surface of Monolayers for the Transepithelial Permeation of Curcumin.

H. Katsumi, A. Yamamoto, A. Tanaka, 2016, Molecular pharmaceutics.

Novel strategy for improving the bioavailability of curcumin based on a new membrane transport mechanism that directly involves solid particles

A. Kiriyama, H. Katsumi, A. Yamamoto, 2018, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Improvement of transdermal delivery of sumatriptan succinate using a novel self-dissolving microneedle array fabricated from sodium hyaluronate in rats.

H. Katsumi, A. Yamamoto, Y. Quan, 2015, Biological & pharmaceutical bulletin.

H. Katsumi, A. Yamamoto, Y. Quan, 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Effects of Manufacturing Methods on Dissolution and Absorption of Ketoconazole in the Presence of Organic Acid as a pH Modifier

Koichi Wada, H. Katsumi, A. Yamamoto, 2017, AAPS PharmSciTech.

Simultaneous Determination of Active Pharmaceutical Ingredients and Water-Soluble Polymers: Analysis of Dissolution Profiles from Sustained-Release Formulations and Mechanisms Involved.

H. Katsumi, A. Yamamoto, T. Sakane, 2022, Chemical & pharmaceutical bulletin.